BEAM
BEAM
US07373V1052
Beam Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.65B EUR
3.54B EUR
2.45B EUR
2.82B EUR
Enterprise Value
1.55B EUR
3.57B EUR
2.41B EUR
2.68B EUR
Valuation Multiples
Trailing P/E
--
--
--
95.83x
Forward P/E
-5.42x
--
--
--
Price to Sales
17.01x
22.71x
14.93x
21.32x
Price to Book
2.41x
3.32x
2.1x
2.28x
EV/Revenue
9.95x
22.89x
14.7x
20.26x
EV/EBITDA
-4.36x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.11%
-10.52%
-15.68%
-8.97%
ende